BioNTech SE - ADR vs Digital Realty Trust, Inc. — how do they compare? BioNTech SE - ADR trades at $93.31 (market cap $23.31B), while Digital Realty Trust, Inc. trades at $196.91 (market cap $70.61B). The key difference: Digital Realty Trust, Inc. is far larger — about 3× BioNTech SE - ADR's market cap, and Digital Realty Trust, Inc. pays a 2.56% dividend while BioNTech SE - ADR pays none. Which is the better fit depends on your goals.
| BNTX | DLR | |
|---|---|---|
Market Cap | $23.31B | $70.61B |
Sector | Health | Real Estate |
52-Week High | $119.34 | $203.91 |
52-Week Low | $83.89 | $147.93 |
Enterprise Value | $6.60B | $89.32B |
Dividend Yield | — | 2.56% |
Signals from Pluang's Aura AI — not financial advice
BioNTech (BNTX) trades at $93.27, up 0.51% on the day, with a bullish technical signal from moving averages and neutral oscillators. The company reported Q2 2026 revenue of $106 million, missing expectations, and lowered its full-year sales outlook due to weak COVID-19 vaccine demand. Despite negative net income margins and cash outflows, BNTX maintains a strong cash position of $16.78 billion and is advancing its oncology pipeline with 14 pivotal clinical trials.
The outlook is mixed: analyst consensus is strongly bullish with a $121 price target, but declining COVID revenue and ongoing losses pose significant risks. Investment opportunity hinges on successful pipeline development, while near-term headwinds from vaccine demand softness and leadership transition require careful monitoring.
DLR trades at $197.02, up 2.99% today, near its consensus price target low of $197.00. The stock shows bullish technical signals with strong moving averages, while fundamentals reveal high valuation multiples (P/E 241.53, P/S 25.08) offset by robust revenue growth to $6.11B in 2025 and a net income margin of 11.8%. Recent Q2 2026 earnings beat expectations with EPS of $1.21 versus $0.48 expected, driven by record leasing activity and raised full-year guidance.
Outlook remains positive due to AI-driven data center demand, but risks include elevated debt levels and cyclical earnings. Analysts are bullish with a $216.56 average target, though premium valuation requires monitoring execution against growth expectations.
Trailing returns across standard periods
Latest headlines on both assets
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →Digital Realty owns and operates nearly 300 data centers worldwide. It has more than 35 million rentable square feet across five continents. Digital's offerings range from retail co-location, where an enterprise may rent a single cabinet and rely on Digital to provide all the accommodations, to cold shells, where hyperscale cloud service providers can simply rent much, or all, of a barren, power-connected building. In recent years, Digital Realty has de-emphasized cold shells and now primarily provides higher-level service to tenants, which outsource their related IT needs to Digital. Digital Realty has also moved more into the co-location business, increasingly serving enterprises and facilitating network connections. Digital Realty operates as a real estate investment trust.
Read more on DLR →